Top PRP Companies Shaping the Future of Regenerative Healing and Orthopedic Care

Platelet Rich Plasma (PRP) therapy can be defined as a type of regenerative medicine which causes natural growth of blood cells in order to heal the damaged tissues in the body. Imagine harnessing the power of natural healing which is hidden in your own blood, that is where PRP technologies concentrate platelets from the blood of a patient for accelerating tissue repair and regeneration. Over the years, the market has grown from sports medicine to orthopedics, rehabilitation, and aesthetics therapies solutions.

Fortune Business Insights stated that the market for platelet rich plasma is thus restructured by these companies by ensuring growth at a rate of 11.30%. By 2034 the market will reach a size of USD 1,388.90 million from USD 513.7 million in 2025.

How PRP Market, through Healing Trends is Redefining Modern Medicine?

The growth in the market is influenced by rising sports injuries, dermatological applications, chronic joint conditions, and increased adoption of regenerative therapies by clinics as well as hospitals. Further, the market is experiencing demand in sectors such as sports medicine, orthopedics, and cosmetic treatments and as per reports PRP is further used in millions of medical procedures annually. The Asia Pacific has witnessed to be one of the rapidly emerging regions owing to clinicians who are adopting PRP for orthopedic and aesthetic uses. However, in order to treat tendon and ligament injuries, sports medicine leads to PRP applications.

Fortune Business Insights Lists Top 5 Platelet Rich Plasma Players Globally

1. Arthrex, Inc.

Arthrex stands as one of the top companies for platelet rich plasma companies across the globe. As of now, the company is recognized for its user-friendly PRP preparation systems ruling in the fields of orthopedic and sports medicine applications. It offers engineered tools for reliable and efficient choice when it comes to tendon repair and joint healing, further making it popular in the clinical as well as surgical healthcare sectors.

The company, as of today, holds a significant share of 33-34% in the PRP market and carries out its operations in more than 90 countries globally. In August 2025, it was honored for product innovation at the 38^th Annual Edison Awards. The company also holds its expertise in surgical technology, manufacturing, medical education, and scientific research.

2. Stryker

Stryker, an orthopedic company founded by Dr. Homer Stryker in 1941, has now evolved into one of the top 5 platelet rich plasma companies in the world. It is also known as a medical technology powerhouse for its high-tech orthopedic implants and surgical equipment. It serves its purpose in the market by offering devices that are used in rehabilitation and surgical procedures. It provides great help to the clinicians in order to deliver enhanced healing outcomes specifically in trauma and joint treatment sectors.

The company functions in two segments such as Neurotechnology & Medsurg and orthopedics & spine. In June 2024, it signed a definitive agreement with Artelon in order to expand its offerings in soft tissue fixation products for ankle and foot. Further, it contributes to sport medicine procedures by providing solutions for tendon and ligament reconstruction.

3. Terumo Corporation

One of the oldest companies in the industry, established in 1921, Terumo Corporation has a century old history in the field of medical innovation. It started as a medical thermometer manufacturer, as of today it has expanded its operations to cellular technologies, blood management, and medical equipment, further including PRP processing systems. The key requirements in the rapidly growing medical setting are high-quality PRP which works consistently and efficiently, and this company has a goal of delivering such solutions to clinics running in the industry.

In October 2024, the Reveos Automated Blood Processing System was launched by the company in the U.S. The launch aimed at helping blood centers to meet platelet and blood supply needs in an efficient manner. Further, it holds a specialization in apheresis, autologous biologics, blood component collection, and cell processing, and has a market presence in around 160 countries with R&D activities and a total of 34 production bases globally.

4. DePuy Synthes (Johnson & Johnson Services, Inc.)

DePuy Synthes, a subsidiary of Johnson & Johnson Services, Inc., founded in 1895 by a chemist named Revra DePuy in Warsaw, Indiana as DePuy Manufacturing. Over the years the company has maintained its decade long position as a leading player in the platelet rich plasma industry. It carries out its operations in over 60 countries globally to fulfil its commitment to orthopedics and surgical treatment technologies. Further, the company is renowned for its functions in bone repair, joint reconstruction, and surgical devices. However, it may not exclusively be a PRP company, its focus toward regenerative medicine comes from supporting tools and systems which often complement PRP treatments in orthopedic care.

DePuy Synthes functions in manufacturing biomaterials such as bioactive glass, cellular bone matrix, demineralized fibers, bone graft substitutes, and others. These materials are often used for customizing treatments for bone healing, joint injuries, and surgical recovery procedures. For instance, in October 2025, the company announced the opening of a new subsidiary in order to accelerate and enhance the portfolio shift of its MedTech Segment.

5. Zimmer Biomet

The company, founded in 1927, is a century old player in the orthopedic and medical devices sector. The founder of Zimmer Biomet, Justin O. Zimmer, started the operations of the company from Warsaw, Indiana as a manufacturer of aluminum splints. As of today it has become one of the top 5 platelet rich plasma players across the globe offering services in joint replacements, musculoskeletal care, and regenerative technologies including PRP systems.

Moreover, in March 2025, in the annual meeting at American Academy of Orthopedic Surgeons (AAOS) 2025, the company highlighted its wide innovations in musculoskeletal and orthopedics. This has helped it to promote its bone graft products at a global platform further boosting its market presence.

Key Players Shaping Future of Healing with Innovation

With rapid growth in the digital landscape, the top 5 platelet rich plasma players in the healthcare industry are also dedicated to implementing technology in healing. By this technique, the players aim to eliminate human error associated with medical treatment. Therefore, they are focused on accelerating the healing process by using the body’s own regenerative power.

Each company listed above functions in combining innovation, deep clinical insight, and global reach in order to make PRP treatments safer, more accessible, and effective than ever before. The major players present in the market promise a future where recovery is more natural, safer, and faster. Thus, whether you are a clinician looking for advanced tools or a patient curious about regenerative therapies, these companies offer a wide portfolio in modern medicine.